|
Volumn 46, Issue DEC., 2000, Pages 2381-2383
|
Drug review "surprises" reader (multiple letters)
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
CLOZAPINE;
CYTOCHROME P450;
FLUOXETINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
PAROXETINE;
PERPHENAZINE;
PROLACTIN;
QUETIAPINE;
RISPERIDONE;
THIORIDAZINE;
ZUCLOPENTHIXOL;
AGE;
AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG INHIBITION;
DRUG METABOLISM;
DRUG SAFETY;
HUMAN;
LETTER;
PALLIATIVE THERAPY;
PROLACTIN BLOOD LEVEL;
PSYCHOPHARMACOTHERAPY;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
AGED;
ALANINE TRANSAMINASE;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CLINICAL TRIALS;
DRUG INTERACTIONS;
DYSKINESIA, DRUG-INDUCED;
HALOPERIDOL;
HUMANS;
LIVER;
MIDDLE AGED;
MULTICENTER STUDIES;
PIRENZEPINE;
PROLACTIN;
RISK FACTORS;
SAFETY;
SCHIZOPHRENIA;
|
EID: 0034495397
PISSN: 0008350X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (0)
|